Staging Lung Cancer

Publication date: May 2018
Source:Radiologic Clinics of North America, Volume 56, Issue 3
Author(s): Ahmed H. El-Sherief, Charles T. Lau, Brett W. Carter, Carol C. Wu

Teaser

This article reviews regional lymph node assessment in lung cancer. In the absence of a distant metastasis, the absence or location of lung cancer spread to a regional mediastinal lymph node affects treatment options and prognosis. Regional lymph node maps have been created to standardize assessment of the N descriptor. The International Association for the Study of Lung Cancer lymph node map is used for the standardization of N descriptor assessment. CT, PET/CT with fluorodeoxyglucose, endobronchial ultrasound–guided and/or esophageal ultrasound–guided biopsy, and mediastinoscopy are common modalities used to determine the N descriptor.


from Radiology via xlomafota13 on Inoreader https://ift.tt/2q1BGAI
via IFTTT